Cost effects of surfactant therapy for neonatal respiratory distress syndrome

This publication has 18 references indexed in Scilit:

• Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams
  The Journal of Pediatrics, 1992
• Cost implications of different approaches to the prevention of respiratory distress syndrome.
  Archives of Disease in Childhood, 1991
• Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome
  The Journal of Pediatrics, 1991
• Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity
  The Journal of Pediatrics, 1991
• A Comparison of Surfactant as Immediate Prophylaxis and as Rescue Therapy in Newborns of Less Than 30 Weeks' Gestation
  New England Journal of Medicine, 1991
• Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trial
  The Journal of Pediatrics, 1991
• Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant
  The Journal of Pediatrics, 1990
• Cost of surfactant replacement treatment for severe neonatal respiratory distress syndrome: a randomised controlled trial.
  BMJ, 1990
• A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress Syndrome
  New England Journal of Medicine, 1989
• The Role of Changing Clinical Practices in the Rising Costs of Hospital Care
  New England Journal of Medicine, 1985